摘要
放射性肺炎(radiation pneumonitis,RP)是胸部放疗的主要剂量限制性因素。严重的RP影响疾病治疗率及预后,目前无有效的治疗或预防措施。早期预测并降低症状性RP的发生对提高胸部放疗疗效意义重大。本篇综述介绍了胸部放疗致RP的有关危险因素与干预措施的相关研究进展。
Radiation pneumonitis(RP)is a major dose-limiting factor in thoracic radiotherapy.Severe RP has a poor effect on the treatment and prognosis of the disease,and there are no effective treatment or preventive measures currently.Early prediction and reduction of symptomatic RP are very important in improving the efficacy of thoracic radiotherapy.This review describes relevant risk factors and interventions for RP caused by thoracic radiotherapy.
作者
张静
谢晓慧(综述)
姚文秀(审校)
Zhang Jing;Xie Xiaohui;Yao Wenxiu(Graduate School,Chengdu Medical College,Chengdu 610000,Sichuan,China;Department of Thoracic Oncology,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,Sichuan,China)
出处
《肿瘤预防与治疗》
2020年第1期81-86,共6页
Journal of Cancer Control And Treatment
基金
吴阶平医学基金会临床科研专项资助基金课题(编号:32.6750.12670)~~
关键词
放射性肺炎
放射性肺损伤
胸部放疗
危险因素
Radiation pneumonitis
Radiation-induced lung injury
Thoracic radiotherapy
Risk factor
